Latest Articles
- Helicobacter pylori: A concise review of the latest treatments against an old foe
H pylori eradication regimens are tailored based on the presence of effective empiric therapy (local cure rates ≥ 90% for a given regimen) or antimicrobial susceptibility testing.
- Digoxin is still useful, but is still causing toxicity
The authors review the presentation of digoxin toxicity, its mechanisms and predisposing factors, and its medical management.
Diabetic retinopathy: Screening, prevention, and treatmentEffective screening processes, timely referrals, and strategic diabetes management are essential to prevent and mitigate the consequences of diabetic retinopathy.
- Persistent erosions of the glans penis and foreskin
A 66-year-old man presented with an 8-month history of persistent erosions of the glans penis and foreskin with slight itching and pain.
- Foxglove, not quite gone or forgotten
Digoxin use has waned dramatically over the past decades, with good reason, but for select patients, it may be a very reasonable option.
- What fluids should I order for my patient with acute pancreatitis?
Recent data show that moderate fluid resuscitation is associated with fewer adverse events and that lactated Ringer’s may be superior to normal saline.
SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internistsThis review summarizes recent data and guidelines regarding SGLT-2 inhibitors in heart failure and chronic kidney disease and provides practical guidance for their use.
- Lymphedema vs lipedema: Similar but different
Lymphedema, lipedema, and even simple obesity in the extremities can resemble each other superficially and are often confused for one another, but they differ in important ways.
- Do patients with sepsis benefit from intravenous albumin?
Patients with sepsis who do not need vasopressors do not benefit from intravenous albumin compared with intravenous crystalloid therapy alone.
- SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
What mechanisms might account for the diverse beneficial effects of the SGLT-2 inhibitors observed across various diseases?